Clinical trial
Outcome Trial (Long Term)to Evaluate the Effects of Cardiac Resynchronization Therapy on the Mortality and Morbidity of Patients With Heart Failure
NCT00170300 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outcome Trial (Long Term)to Evaluate the Effects of Cardiac Resynchronization Therapy on the Mortality and Morbidity of Patients With Heart Failure
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2001
- Completion date
- May 31, 2005
- Enrollment
- 813
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.